Close
Nordic 9Nordic 9

Genoskin (private company)

France genoskin.com
See something wrong or missing? Let us know
Offices:Toulouse
Industry:BiotechHealth servicesManufacturingPharma
Business model:B2B

Genoskin is a biotech startup in France developing ex vivo human skin platforms capable of testing injected drugs and implanted medical devices

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 9.32M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Genoskin

Name Criteria
Denmark Biograil
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
Spain Cebiotex
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France Cell-Easy
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Norway Curida
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Denmark Octarine Bio
60%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 5M - 10M USD
Austria Sarcura
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
Spain ViveBiotech
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Italy Harg
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 5M - 10M USD
Top